nuclear receptor corepressor 2; N-CoR2; silencing mediator of retinoic acid & thyroid hormone receptor; SMRT; thyroid-, retinoic-acid-receptor-associated corepressor; T3 receptor-associating factor; TRAC; CTG repeat protein 26; SMAP270 (NCOR2, CTG26)
Jump to navigation
Jump to search
Function
- interacts with unliganded nuclear receptors, including RXR, RAR, T3R, PPAR-alpha & PPAR-gamma to keep them in a repressed state
- mediates transcriptional repression activity of some nuclear receptors by promoting chromatin condensation, thus preventing access of the basal transcription
- isoform 1 & isoform 5 have different affinities for different nuclear receptors
- interacts with HDAC7 (putative)
- forms a large corepressor complex that contains SIN3A/B & histone deacetylases HDAC1 & HDAC2
- isoform SRMT interacts with HDAC10
- interacts with MINT
- component of the N-cor repressor complex
- interacts with CBFA2T3
- interacts with C1D
- interacts with ATXN1L
- interacts with BCL6 (directly)
Structure
- the N-terminal region contains repression functions that are divided into 3 independent repression domains (RD1, RD2 & RD3)
- the C-terminal region contains the nuclear receptor-interacting domains that are divided in 2 separate interaction domains (ID1 & ID2)
- the 2 interaction domains (ID) contain a conserved sequence referred to as the CORNR box
- the CORNR box is required & sufficient to permit binding to unligated erbA & RAR
- sequences flanking the CORNR box determine nuclear hormone receptor specificity
- belongs to the N-CoR nuclear receptor corepressors family
- contains 2 SANT domains
Compartment
Alternative splicing
- named isoforms=5
- contains only the C-terminal receptor-interacting domain & acts as an antirepressor
Expression
- ubiquitous
- high levels of expression are detected in lung, spleen & brain
- regulated during cell cycle progression
Pathology
- loss of NCOR2 expression may accelerate resistance to androgen deprivation therapy in prostate cancer[3]
More general terms
Component of
References
- ↑ UniProt http://www.uniprot.org/uniprot/Q9Y618.html
- ↑ Corton JC, Anderson SP, Stauber A. Central role of peroxisome proliferator-activated receptors in the actions of peroxisome proliferators. Annu Rev Pharmacol Toxicol. 2000;40:491-518. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/10836145
- ↑ 3.0 3.1 Larkin M Loss, Mutation of NCOR2 Likely Fuels Prostate Cancer Progression, Resistance. Medscape. December 23, 2021 https://www.medscape.com/viewarticle/965465
Long MD, Jacobi JJ, Singh PK et al Reduced NCOR2 expression accelerates androgen deprivation therapy failure in prostate cancer. Cell Reports 2021. 37(11):110109 https://www.sciencedirect.com/science/article/pii/S221112472101603X